Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-04-30

Clinical Trial Update: Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic Myeloproliferative Neoplasms [Phase 2]

View source ↗

Summary

This clinical trial update describes a long-term Phase 2 study of Givinostat in patients with chronic myeloproliferative neoplasms and notes the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Givinostat (givinostat)

Snippet

Sponsor: Italfarmaco | Conditions: Chronic Myeloproliferative Neoplasms | Phase 2 | Status: ACTIVE_NOT_RECRUITING